Cwm LLC Grows Position in CVS Health Corporation (NYSE:CVS)

CWM LLC lifted its position in CVS Health Corporation (NYSE:CVS - Free Report) by 155.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 103,804 shares of the pharmacy operator's stock after acquiring an additional 63,121 shares during the period. CWM LLC's holdings in CVS Health were worth $7,033,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently made changes to their positions in the company. Madison Investment Advisors LLC acquired a new position in CVS Health during the fourth quarter worth $6,233,000. SouthState Corp boosted its stake in CVS Health by 849.6% during the fourth quarter. SouthState Corp now owns 26,989 shares of the pharmacy operator's stock worth $1,212,000 after buying an additional 24,147 shares during the last quarter. Cibc World Markets Corp boosted its stake in CVS Health by 16.4% during the fourth quarter. Cibc World Markets Corp now owns 198,542 shares of the pharmacy operator's stock worth $8,913,000 after buying an additional 27,985 shares during the last quarter. Cozad Asset Management Inc. boosted its stake in CVS Health by 3.7% during the fourth quarter. Cozad Asset Management Inc. now owns 6,532 shares of the pharmacy operator's stock worth $293,000 after buying an additional 233 shares during the last quarter. Finally, RD Lewis Holdings Inc. acquired a new position in CVS Health during the fourth quarter worth $244,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director directly owned 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 1.22% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CVS shares. Barclays set a $79.00 price target on CVS Health and gave the company an "overweight" rating in a research note on Monday, June 2nd. Royal Bank Of Canada upped their price target on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Piper Sandler upped their price target on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Jefferies Financial Group upped their price target on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Finally, Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Two analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $75.06.

CVS Health Stock Performance

Shares of NYSE CVS traded down $0.51 during trading hours on Thursday, reaching $63.29. The stock had a trading volume of 3,911,392 shares, compared to its average volume of 10,747,233. The firm has a market cap of $80.06 billion, a price-to-earnings ratio of 15.10, a PEG ratio of 0.91 and a beta of 0.57. The company has a current ratio of 0.82, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $72.51. The firm has a 50-day moving average of $64.89 and a 200-day moving average of $62.63.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. During the same period last year, the firm earned $1.31 EPS. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. Equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd will be issued a $0.665 dividend. The ex-dividend date is Tuesday, July 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.20%. CVS Health's dividend payout ratio is currently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.